Artificial Intelligence-Focused Companies Advance ProgrammingAllbiopro2019-07-17T09:59:10+09:007월 17th, 2019|
New Hope for Rare Mitochondrial Diseases: An Interview With Minovia Therapeutics’ Natalie Yivgi OhanaAllbiopro2019-07-17T09:58:38+09:007월 17th, 2019|
Selectively Targeting Cancerous T-Cells Using CAR-T TherapyAllbiopro2019-07-17T09:57:36+09:007월 17th, 2019|
Genentech Strikes Three Separate Drug Discovery Deals With Small CompaniesAllbiopro2019-07-17T09:57:04+09:007월 17th, 2019|
Gilead’s Kite builds cell therapy manufacturing quickly even as Yescarta sales grow slowlyAllbiopro2019-07-17T09:56:34+09:007월 17th, 2019|
Evoke taps new president for North America, continues talent expansionAllbiopro2019-07-17T09:56:00+09:007월 17th, 2019|
Who’s toughest on drug prices? Watch Trump and his 2020 challengers wrestle for the titleAllbiopro2019-07-17T09:55:32+09:007월 17th, 2019|
J&J execs have plenty to brag about in pharma. Why downplay Xarelto, Zytiga woes?Allbiopro2019-07-17T09:55:02+09:007월 17th, 2019|
Novartis’ crizanlizumab wins speedy FDA review, putting it closer to blockbuster sickle cell launchAllbiopro2019-07-17T09:54:33+09:007월 17th, 2019|
Migraine patient or doctor? Demand more, Biohaven advises in new awareness pushAllbiopro2019-07-17T09:53:59+09:007월 17th, 2019|
J&J called ‘kingpin’ of Oklahoma opioid epidemic. Will a judge agree?Allbiopro2019-07-17T09:53:27+09:007월 17th, 2019|
Notable Labs lands $40M to expand AI-based cancer treatment techAllbiopro2019-07-17T09:52:28+09:007월 17th, 2019|
Trefoil Therapeutics banks $28M to create first drug for genetic eye disorderAllbiopro2019-07-17T09:51:55+09:007월 17th, 2019|
Sosei Heptares pens $1B biobucks GPCR pact with GenentechAllbiopro2019-07-17T09:51:26+09:007월 17th, 2019|
FDA contributes to hunt for new heart failure endpointsAllbiopro2019-07-17T09:50:53+09:007월 17th, 2019|
CDMOs driving drug conjugate innovation, says ADC BioAllbiopro2019-07-17T09:50:21+09:007월 17th, 2019|
